Cargando…

Cerebrospinal fluid cytokines in geriatric patients with depressive disorders: A retrospective case-control study

Central nervous system inflammation might play a role in patients with depressive disorders. This hypothesis is supported by studies reporting increased cerebrospinal fluid levels of the inflammatory markers interleukin (IL)-6, IL-8 and tumor necrosis factor alpha (TNF-α) in patients with ongoing de...

Descripción completa

Detalles Bibliográficos
Autores principales: Schou, Morten Brix, Larsen, Jeanette Brun, Stunes, Astrid Kamilla, Sæther, Sverre Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510363/
https://www.ncbi.nlm.nih.gov/pubmed/36172507
http://dx.doi.org/10.3389/fpsyt.2022.947605
_version_ 1784797425241686016
author Schou, Morten Brix
Larsen, Jeanette Brun
Stunes, Astrid Kamilla
Sæther, Sverre Georg
author_facet Schou, Morten Brix
Larsen, Jeanette Brun
Stunes, Astrid Kamilla
Sæther, Sverre Georg
author_sort Schou, Morten Brix
collection PubMed
description Central nervous system inflammation might play a role in patients with depressive disorders. This hypothesis is supported by studies reporting increased cerebrospinal fluid levels of the inflammatory markers interleukin (IL)-6, IL-8 and tumor necrosis factor alpha (TNF-α) in patients with ongoing depression. In this case-control study, we aimed to examine whether these findings also applied to depressed patients in a geriatric population. Cerebrospinal fluid cytokine analyses were performed on 15 patients (age >60 years) with depressive disorders and 45 age– and sex matched controls (patients with headache or idiopathic facial palsy). IL-6, IL-8, IL-10, TNF-α, monocyte chemoattractant protein-1 and transforming growth factor beta 1 were included in the statistical analyses. Patients with depression had significantly lower cerebrospinal fluid levels of IL-6 as compared to controls (p = 0.014) in the univariate analysis. The finding was, however, no longer statistically significant after correction for age and body mass index (p = 0.097). Overall, this study indicates that the cytokines included in this study are not significantly altered in geriatric patients with depression. Future studies exploring cerebrospinal fluid cytokine levels should include corrections for possible confounding factors.
format Online
Article
Text
id pubmed-9510363
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95103632022-09-27 Cerebrospinal fluid cytokines in geriatric patients with depressive disorders: A retrospective case-control study Schou, Morten Brix Larsen, Jeanette Brun Stunes, Astrid Kamilla Sæther, Sverre Georg Front Psychiatry Psychiatry Central nervous system inflammation might play a role in patients with depressive disorders. This hypothesis is supported by studies reporting increased cerebrospinal fluid levels of the inflammatory markers interleukin (IL)-6, IL-8 and tumor necrosis factor alpha (TNF-α) in patients with ongoing depression. In this case-control study, we aimed to examine whether these findings also applied to depressed patients in a geriatric population. Cerebrospinal fluid cytokine analyses were performed on 15 patients (age >60 years) with depressive disorders and 45 age– and sex matched controls (patients with headache or idiopathic facial palsy). IL-6, IL-8, IL-10, TNF-α, monocyte chemoattractant protein-1 and transforming growth factor beta 1 were included in the statistical analyses. Patients with depression had significantly lower cerebrospinal fluid levels of IL-6 as compared to controls (p = 0.014) in the univariate analysis. The finding was, however, no longer statistically significant after correction for age and body mass index (p = 0.097). Overall, this study indicates that the cytokines included in this study are not significantly altered in geriatric patients with depression. Future studies exploring cerebrospinal fluid cytokine levels should include corrections for possible confounding factors. Frontiers Media S.A. 2022-09-12 /pmc/articles/PMC9510363/ /pubmed/36172507 http://dx.doi.org/10.3389/fpsyt.2022.947605 Text en Copyright © 2022 Schou, Larsen, Stunes and Sæther. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Schou, Morten Brix
Larsen, Jeanette Brun
Stunes, Astrid Kamilla
Sæther, Sverre Georg
Cerebrospinal fluid cytokines in geriatric patients with depressive disorders: A retrospective case-control study
title Cerebrospinal fluid cytokines in geriatric patients with depressive disorders: A retrospective case-control study
title_full Cerebrospinal fluid cytokines in geriatric patients with depressive disorders: A retrospective case-control study
title_fullStr Cerebrospinal fluid cytokines in geriatric patients with depressive disorders: A retrospective case-control study
title_full_unstemmed Cerebrospinal fluid cytokines in geriatric patients with depressive disorders: A retrospective case-control study
title_short Cerebrospinal fluid cytokines in geriatric patients with depressive disorders: A retrospective case-control study
title_sort cerebrospinal fluid cytokines in geriatric patients with depressive disorders: a retrospective case-control study
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510363/
https://www.ncbi.nlm.nih.gov/pubmed/36172507
http://dx.doi.org/10.3389/fpsyt.2022.947605
work_keys_str_mv AT schoumortenbrix cerebrospinalfluidcytokinesingeriatricpatientswithdepressivedisordersaretrospectivecasecontrolstudy
AT larsenjeanettebrun cerebrospinalfluidcytokinesingeriatricpatientswithdepressivedisordersaretrospectivecasecontrolstudy
AT stunesastridkamilla cerebrospinalfluidcytokinesingeriatricpatientswithdepressivedisordersaretrospectivecasecontrolstudy
AT sæthersverregeorg cerebrospinalfluidcytokinesingeriatricpatientswithdepressivedisordersaretrospectivecasecontrolstudy